Showing results (451-460 of 472) with videos related to
Sort By:
Pageof 48
Clinical Therapeutics|August 10, 2016
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan MonotherapyKwang-Il Kim, Mi-Seung Shin, Sang-Hyun Ihm, et al.Trials|July 3, 2019
Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trialMin-Gu Kang, Kwang-Il Kim, Sang Hyun Ihm, et al.Hypertension (Dallas, Tex. : 1979)|February 20, 2026
Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCTJeong Cheon Ahn, Cheol Whan Lee, Jong Hwa Ahn, et al.International Urology and Nephrology|May 10, 2017
The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinomaYang Hyun Cho, Jun Eul Hwang, Ho Seok Chung, et al.Clinical Therapeutics|April 9, 2015
A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential HypertensionHae-Young Lee, Yong-Jin Kim, Taehoon Ahn, et al.Clinical Therapeutics|September 14, 2025
Efficacy and Safety of Fimasartan, Atorvastatin, and Ezetimibe Combination Therapy in Patients With Hypertension and Dyslipidemia: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical TrialSoon Jun Hong, Ju Hyeon Kim, Kwang Soo Cha, et al.Journal of Clinical Medicine|March 6, 2021
Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort StudyIn-Jeong Cho, Jeong-Hun Shin, Mi-Hyang Jung, et al.Korean Circulation Journal|April 7, 2022
Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood Pressure TargetsDae-Hee Kim, In-Jeong Cho, Woohyeun Kim, et al.Journal of the American Heart Association|March 15, 2021
Disparities in Mortality and Cardiovascular Events by Income and Blood Pressure Levels Among Patients With Hypertension in South KoreaJeong-Hun Shin, Mi-Hyang Jung, Chang Hee Kwon, et al.Nature Communications|September 27, 2022
Combined IgE neutralization and Bifidobacterium longum supplementation reduces the allergic response in models of food allergySeong Beom An, Bo-Gie Yang, Gyeonghui Jang, et al.Pageof 48